Kiniksa Pharmaceuticals (KNSA) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

What defines a successful crypto expert? The amount of money earned, the number of luxury cars and international real estate? The presence of…
Features of exchanging USDC ERC20 to Bank Transfer

March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer

You can use electronic exchange services if you need to exchange the digital asset USDC ERC20 to Bank Transfer. It is not recommended…
Why Stock Caps Matter When Building a Diversified Portfolio

February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio

Most investors who want to expand their investment options put their money in different asset types and industries across many areas in the…
Top 5 Coins for the Maximum Passive Income from Staking by 2024

February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024

Staking is one of the ways that is now being used as a secure and profitable way to earn money without doing anything…
Trading Stocks With AI: A Modern Approach

January 21, 2025 Trading Stocks With AI: A Modern Approach

The stock market can feel overwhelming, especially with its constant ups and downs. Trading stocks with AI is revolutionizing how investors analyze trends,…

Kiniksa Pharmaceuticals (KNSA) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: May 15, 2025 (22:26)

Sector: Healthcare

The share price of Kiniksa Pharmaceuticals, Ltd. (KNSA) now

Latest session on the 14th of May for
Kiniksa Pharmaceuticals, Ltd. is negative
Trading Volume: 555517
Open: 25.6 /  High: 25.845 /  Low: 24.85
Current value: $25.03
What analysts predict: $37.57
52-week High/Low: $28.56 / $25.97
50-Day Moving Average: $22.2 — support level today
200-Day Moving Average: $22.74 — support level today

Are you interested in Kiniksa Pharmaceuticals, Ltd. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Kiniksa Pharmaceuticals stock price in 2025, 2026, 2027. How much will one Kiniksa Pharmaceuticals share be worth in 2025 - 2027?

When should I take profit in Kiniksa Pharmaceuticals stock? When should I record a loss on Kiniksa Pharmaceuticals stock? What are analysts' forecasts for Kiniksa Pharmaceuticals stock? What is the future of Kiniksa Pharmaceuticals stock? We forecast Kiniksa Pharmaceuticals stock performance using neural networks based on historical data on Kiniksa Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Kiniksa Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Kiniksa Pharmaceuticals shares. This happens once a day.


Historical and forecast chart of Kiniksa Pharmaceuticals stock

The chart below shows the historical price of Kiniksa Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Kiniksa Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Kiniksa Pharmaceuticals, Ltd., a clinical stage biopharmaceutical company, specializes in the discovery, acquisition, development and commercialization of therapeutic drugs for severely ill patients with significant unmet medical needs around the world.

Trending Themes in the Healthcare Sector

Kiniksa Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
May 17 24.91 24.32 25.09 3.13
May 18 24.82 24.45 25.16 2.89
May 19 24.28 23.73 24.82 4.57
May 20 24.35 24.05 24.79 3.10
May 21 24.92 24.35 25.43 4.45
May 22 24.96 24.46 25.48 4.19
May 23 25.29 24.71 25.74 4.18
May 24 25.46 25.19 25.78 2.34
May 25 25.72 25.24 26.24 3.97
May 26 25.62 25.36 25.82 1.79
May 27 25.29 24.92 25.88 3.84
May 28 25.19 24.90 25.56 2.67
May 29 25.23 24.63 25.54 3.69
May 30 25.16 24.70 25.40 2.84
May 31 25.84 25.49 26.29 3.13
Jun 01 26.43 25.91 26.99 4.16
Jun 02 27.02 26.83 27.42 2.18
Jun 03 27.81 27.16 27.98 3.01
Jun 04 27.90 27.70 28.47 2.81
Jun 05 27.92 27.42 28.19 2.81
Jun 06 27.91 27.55 28.35 2.89
Jun 07 27.18 26.74 27.67 3.48
Jun 08 27.08 26.86 27.36 1.88
Jun 09 26.97 26.63 27.26 2.40
Jun 10 27.65 27.12 28.12 3.67
Jun 11 28.24 27.59 28.57 3.56
Jun 12 27.71 27.43 28.32 3.24
Jun 13 27.28 26.72 27.58 3.22
Jun 14 27.55 27.32 28.08 2.81
Jun 15 27.58 27.12 28.23 4.09

Kiniksa Pharmaceuticals Daily Price Targets


Kiniksa Pharmaceuticals Stock Forecast 05-17-2025.

Forecast target price for 05-17-2025: $24.91.
Negative dynamics for Kiniksa Pharmaceuticals shares will prevail with possible volatility of 3.038%.
Pessimistic target level: 24.32
Optimistic target level: 25.09

Kiniksa Pharmaceuticals Stock Forecast 05-18-2025.

Forecast target price for 05-18-2025: $24.82.
Negative dynamics for Kiniksa Pharmaceuticals shares will prevail with possible volatility of 2.812%.
Pessimistic target level: 24.45
Optimistic target level: 25.16

Kiniksa Pharmaceuticals Stock Forecast 05-19-2025.

Forecast target price for 05-19-2025: $24.28.
Negative dynamics for Kiniksa Pharmaceuticals shares will prevail with possible volatility of 4.373%.
Pessimistic target level: 23.73
Optimistic target level: 24.82

Kiniksa Pharmaceuticals Stock Forecast 05-20-2025.

Forecast target price for 05-20-2025: $24.35.
Positive dynamics for Kiniksa Pharmaceuticals shares will prevail with possible volatility of 3.006%.
Pessimistic target level: 24.05
Optimistic target level: 24.79

Kiniksa Pharmaceuticals Stock Forecast 05-21-2025.

Forecast target price for 05-21-2025: $24.92.
Positive dynamics for Kiniksa Pharmaceuticals shares will prevail with possible volatility of 4.263%.
Pessimistic target level: 24.35
Optimistic target level: 25.43

Kiniksa Pharmaceuticals Stock Forecast 05-22-2025.

Forecast target price for 05-22-2025: $24.96.
Positive dynamics for Kiniksa Pharmaceuticals shares will prevail with possible volatility of 4.025%.
Pessimistic target level: 24.46
Optimistic target level: 25.48

KNSA (KNSA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jun. 27.25 25.12 28.59 12.14
Jul. 28.74 27.80 31.58 11.95
Aug. 30.01 28.29 32.78 13.69
Sep. 29.97 27.51 33.04 16.74
Oct. 27.55 25.80 29.24 11.76
Nov. 26.62 23.99 28.94 17.10
Dec. 30.05 29.23 33.09 11.69

Kiniksa Pharmaceuticals forecast for this year


Kiniksa Pharmaceuticals Stock Prediction for Jun 2025

An uptrend is forecast for this month with an optimal target price of $27.2482. Pessimistic: $25.12. Optimistic: $28.59


Kiniksa Pharmaceuticals Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $28.736. Pessimistic: $27.80. Optimistic: $31.58


Kiniksa Pharmaceuticals Stock Prediction for Aug 2025

An uptrend is forecast for this month with an optimal target price of $30.0061. Pessimistic: $28.29. Optimistic: $32.78


Kiniksa Pharmaceuticals Stock Prediction for Sep 2025

An downtrend is forecast for this month with an optimal target price of $29.9671. Pessimistic: $27.51. Optimistic: $33.04


Kiniksa Pharmaceuticals Stock Prediction for Oct 2025

An downtrend is forecast for this month with an optimal target price of $27.5517. Pessimistic: $25.80. Optimistic: $29.24


Kiniksa Pharmaceuticals Stock Prediction for Nov 2025

An downtrend is forecast for this month with an optimal target price of $26.6205. Pessimistic: $23.99. Optimistic: $28.94


Kiniksa Pharmaceuticals Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $30.0465. Pessimistic: $29.23. Optimistic: $33.09



Kiniksa Pharmaceuticals (KNSA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 31.57 29.97 32.84 8.75
Feb 33.25 30.36 35.33 14.07
Mar 32.09 29.83 35.01 14.78
Apr 31.58 28.67 33.35 14.04
May 28.34 27.13 29.52 8.11
Jun 27.46 26.10 28.60 8.74
Jul 28.88 27.65 30.99 10.78
Aug 27.87 25.95 30.44 14.76
Sep 31.49 29.24 33.58 12.92
Oct 33.83 30.88 36.03 14.28
Nov 33.34 31.65 34.90 9.31
Dec 31.91 31.04 34.40 9.77

Kiniksa Pharmaceuticals (KNSA) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 29.34 27.82 31.40 11.42
Feb 31.17 28.90 33.60 13.99
Mar 30.12 27.34 32.51 15.90
Apr 30.82 28.42 33.59 15.39
May 33.87 32.55 36.64 11.17
Jun 34.97 33.65 37.15 9.42
Jul 35.70 33.75 37.79 10.68
Aug 39.97 37.84 41.58 9.00
Sep 38.98 35.79 40.55 11.75
Oct 36.19 34.03 39.34 13.51
Nov 37.84 34.64 39.07 11.33
Dec 35.48 33.59 36.72 8.54

Kiniksa Pharmaceuticals information and performance

Kiniksa Pharmaceuticals Address

CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON, BM

Market Capitalization: 1 899 435 000 $

Market capitalization of the Kiniksa Pharmaceuticals, Ltd. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of KNSA shares in the company outstanding by the market price of one share.

EBITDA: -14 228 000 $

EBITDA of Kiniksa Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.24

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 5.5
Quarterly Revenue Growth YOY: 0.725
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.41

Enterprise Value (EV) /Revenue

EV To EBITDA: -44.93

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 42336200

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Kiniksa Pharmaceuticals Stock)

Should I Buy Kiniksa Pharmaceuticals Shares in 2025 year?

The maximum forecasted share price for next year is $33.83, which is $8.80 higher than the current stock price. By investing in Kiniksa Pharmaceuticals shares today for a one-year period, you could achieve a profit of 35.15%. With an investment horizon of up to two years, the target share price is $39.97. resulting in a profit of 59.67% ($14.94 per share).

Does Kiniksa Pharmaceuticals pay dividends?

No, it does not

Which economic sector do Kiniksa Pharmaceuticals's shares belong to?

Kiniksa Pharmaceuticals's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Kiniksa Pharmaceuticals's shares?

You can view all the stocks that are part of the same sector as Kiniksa Pharmaceuticals's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.